Bożena Bruhn-Olszewska

Bożena Bruhn-Olszewska

Auto-generated profile, based on publicly available information

Bożena Bruhn-Olszewska

Department of Immunology, Genetics and Pathology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KLK. M. Lawrence
K. M. Lawrence
RJR. C. Jones
R. C. Jones
TJT. R. Jackson
T. R. Jackson
RBR. L. Baylie
R. L. Baylie
BAB. Abbott
B. Abbott
PTPaul Townsend
Paul Townsend
Osteoarthritis (OA) is characterised by progressive destruction of articular cartilage and chondrocyte cell death. Here, we show the expression of the endogenous peptide urocortin1 (Ucn1) and two receptor subtypes, CRF-R1 and CRF-R2, in primary human articular chondrocytes (AC) and demonstrate its role as an autocrine/paracrine pro-survival factor. This effect could only be removed using the CRF-R1 selective antagonist CP-154526, suggesting Ucn1 acts through CRF-R1 when promoting chondrocyte survival. This cell death was characterised by an increase in p53 expression, and cleavage of caspase 9 and 3. Antagonism of CRF-R1 with CP-154526 caused an accumulation of intracellular calcium (Ca2+) over time and cell death. These effects could be prevented with the non-selective cation channel blocker Gadolinium (Gd3+). Therefore, opening of a non-selective cation channel causes cell death and Ucn1 maintains this channel in a closed conformation. This channel was identified to be the mechanosensitive channel Piezo1. We go on to determine that this channel inhibition by Ucn1 is mediated initially by an increase in cyclic adenosine monophosphate (cAMP) and a subsequent inactivation of phospholipase A2 (PLA2), whose metabolites are known to modulate ion channels. Knowledge of these novel pathways may present opportunities for interventions that could abrogate the progression of OA.

2 January 2025 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
BBBozena Bruhn-Olszewska
Bozena Bruhn-Olszewska
EMEllen Markljung
Ellen Markljung
EREdyta Rychlicka-Buniowska
Edyta Rychlicka-Buniowska
DSDaniil Sarkisyan
Daniil Sarkisyan
NFNatalia Filipowicz
Natalia Filipowicz
JDJan Piotr Dumanski
Jan Piotr Dumanski

18 December 2012 in Acta Biochimica Polonica
Verified
Journal Article
Open access
PDF file
BBBożena Bruhn-Olszewska
Bożena Bruhn-Olszewska
AKAnna Korzon-Burakowska
Anna Korzon-Burakowska
Magdalena Gabig-CimińskaMagdalena Gabig-Cimińska
Magdalena Gabig-Cimińska
POPaweł Olszewski
Paweł Olszewski
Alicja WęgrzynAlicja Węgrzyn
Alicja Węgrzyn
JJJoanna Jakóbkiewicz-Banecka
Joanna Jakóbkiewicz-Banecka
Diabetes is one of the major challenges of modern medicine, as it is considered a global epidemic of the XXI century. The disease often leads to the development of serious, health threatening complications. Diabetic foot syndrome is a characteristic set of anatomical and molecular changes. At the macroscopic level, major symptoms are neuropathy, ischemia and chronic ulceration of the lower limb. In every third patient, the neuropathy develops into Charcot neuroarthropathy characterized by bone and joints deformation. Interestingly, all these complications are a result of impaired healing processes and are characteristic for diabetes. The specificity of these symptoms comes from impaired molecular mechanisms observed in type 1 and type 2 diabetes. Decreased wound and fracture healing reflect gene expression, cellular response, cell functioning and general metabolism. Here we present a comprehensive literature update on the molecular factors contributing to diabetic foot syndrome.

29 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BBBożena Bruhn-Olszewska
Bożena Bruhn-Olszewska
AKAnna Korzon-Burakowska
Anna Korzon-Burakowska
Grzegorz WęgrzynGrzegorz Węgrzyn
Grzegorz Węgrzyn
JJJoanna Jakóbkiewicz-Banecka
Joanna Jakóbkiewicz-Banecka
Charcot arthropathy is one of the most serious complications of diabetic foot syndrome that leads to amputation of the affected limb. Since there is no cure for Charcot arthropathy, early diagnosis and implementation preventive care are the best available treatment. However, diagnosis is hindered by obscure clinical picture of the disease and lack of molecular markers for its early detection. Results of recent research suggest that OPG-RANKL-RANK axis regulating bone metabolism can be associated with Charcot arthropathy and that SNPs in OPG gene are associated with the disease. Here we report the results of comprehensive analysis of ten SNPs in OPG, RANKL and RANK genes in 260 subjects divided into diabetes, neuropathy and Charcot arthropathy groups. Besides genotype analysis we performed linkage disequilibrium and hierarchical clustering to obtain information about correlation between SNPs. Our results show that OPG 245T/G (rs3134069) and OPG 1217C/T (rs3102734) polymorphisms co-occur in patients with Charcot arthropathy (r2 = 0.99). Moreover, hierarchical clustering revealed a characteristic profile of all SNPs in Charcot arthropathy and neuropathy, which is distinct from control group. Our results suggest that analysis of multiple SNPs can be used as potential marker of Charcot arthropathy and provide insight into possible molecular mechanisms of its development.

Verified
Journal Article
Open access
PDF file
BSBartosz Sobocki
Bartosz Sobocki
CBCharbel Basset
Charbel Basset
BBBożena Bruhn-Olszewska
Bożena Bruhn-Olszewska
POPaweł Olszewski
Paweł Olszewski
OSOlga Szot
Olga Szot
Angelo LeoneAngelo Leone
Angelo Leone
Periodontitis is prevalent in half of the adult population and raises critical health concerns as it has been recently associated with an increased risk of cancer. While information about the topic remains somewhat scarce, a deeper understanding of the underlying mechanistic pathways promoting neoplasia in periodontitis patients is of fundamental importance. This manuscript presents the literature as well as a panel of tables and figures on the molecular mechanisms of Porphyromonas gingivalis and Fusobacterium nucleatum, two main oral pathogens in periodontitis pathology, involved in instigating tumorigenesis. We also present evidence for potential links between the RANKL–RANK signaling axis as well as circulating cytokines/leukocytes and carcinogenesis. Due to the nonconclusive data associating periodontitis and cancer reported in the case and cohort studies, we examine clinical trials relevant to the topic and summarize their outcome.

14 December 2022 in Genome Medicine
Verified
Journal Article
Open access
PDF file
BBBożena Bruhn-Olszewska
Bożena Bruhn-Olszewska
HDHanna Davies
Hanna Davies
DSDaniil Sarkisyan
Daniil Sarkisyan
UJUlana Juhas
Ulana Juhas
EREdyta Rychlicka-Buniowska
Edyta Rychlicka-Buniowska
JDJan Piotr Dumanski
Jan Piotr Dumanski
Background: The COVID-19 pandemic, which has a prominent social and economic impact worldwide, shows a largely unexplained male bias for the severity and mortality of the disease. Loss of chromosome Y (LOY) is a risk factor candidate in COVID-19 due to its prior association with many chronic age-related diseases, and its impact on immune gene transcription.Methods: Publicly available scRNA-seq data of PBMC samples derived from male patients critically ill with COVID-19 were reanalyzed, and LOY status was added to the annotated cells. We further studied LOY in whole blood for 211 COVID-19 patients treated at intensive care units (ICU) from the first and second waves of the pandemic. Of these, 139 patients were subject to cell sorting for LOY analysis in granulocytes, low-density neutrophils (LDNs), monocytes, and PBMCs.Results: Reanalysis of available scRNA-seq data revealed LDNs and monocytes as the cell types most affected by LOY. Subsequently, DNA analysis indicated that 46%, 32%, and 29% of critically ill patients showed LOY above 5% cut-off in LDNs, granulocytes, and monocytes, respectively. Hence, the myeloid lineage that is crucial for the development of severe COVID-19 phenotype is affected by LOY. Moreover, LOY correlated with increasing WHO score (median difference 1.59%, 95% HDI 0.46% to 2.71%,p=0.025), death during ICU treatment (median difference 1.46%, 95% HDI 0.47% to 2.43%,p=0.0036), and history of vessel disease (median difference 2.16%, 95% HDI 0.74% to 3.7%,p=0.004), among other variables. In 16 recovered patients, sampled during ICU stay and 93–143 days later, LOY decreased significantly in whole blood and PBMCs. Furthermore, the number of LDNs at the recovery stage decreased dramatically (median difference 76.4 per 10,000 cell sorting events, 95% HDI 55.5 to 104,p=6e−11).Conclusions: We present a link between LOY and an acute, life-threatening infectious disease. Furthermore, this study highlights LOY as the most prominent clonal mutation affecting the myeloid cell lineage during emergency myelopoiesis. The correlation between LOY level and COVID-19 severity might suggest that this mutation affects the functions of monocytes and neutrophils, which could have consequences for male innate immunity.